Daniel J. Czyzyk

Frederick National Laboratory for Cancer Research

Immunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors”.

Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors

Bioorganic & Medicinal Chemistry Letters(2020)10.1016/j.bmcl.2020.127292

N/A

0DataRank · unranked

3 citations

Daniel J. Czyzyk, Vidya P. Kumar, William L. Jorgensen, Karen S. Anderson, Victor G. Ruiz

Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection

RSC Pharmaceutics(2024)10.1039/d4pm00093e

N/A

0DataRank · unranked

1 citations

Daniel J. Czyzyk, Griselle Martinez-Traverso, Aygül Sadıqova, Margarita Valhondo, Deborah A. Schaefer +7 more

Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation

Nature Communications(2025)10.1038/s41467-024-55766-x

N/A

0DataRank · unranked

32 citations

Wupeng Yan, Simon Messing, William Gillette, Takashi Tsuji, Mitsuhiro Yamaguchi +7 more